From “Terminal” to Triumph
When Cheryl first heard the words “stage IV melanoma,” her world stopped. Doctors told her that treatments for her diagnosis hadn’t changed in 25 years, that her options were limited, and that she should enjoy the holidays with her family— it might be her last.
But Cheryl refused to give up. With persistence, hope, and the support of her family, she fought for answers. What followed was a relentless search for a clinical trial, countless phone calls, and determination that carried her across the country. Against all odds, Cheryl found a groundbreaking clinical trial at UCLA—and became what doctors called a “super responder.” The therapy not only saved her life but also helped pave the way for new treatments that are now available to patients worldwide.
In the latest episode of All Things Cancer, NFCR President and CEO Dr. Sujuan Ba speaks with Cheryl about:
- The shock of hearing her diagnosis—and why she refused to accept “no” for an answer
- How she found and enrolled in a life-saving clinical trial when options seemed nonexistent
- The difficult side effects she endured as one of the earliest patients in the trial
- Why melanoma research has advanced so rapidly, and how it impacts many other cancers
- Her advice for patients, families, and doctors on hope, persistence, and advocacy
Cheryl’s story is more than one of survival—it’s about transformation, resilience, and the power of research to change lives. Today, she continues to support other patients through advocacy and by sharing her message: never give up hope.
About All Things Cancer
Each episode of All Things Cancer will spotlight the most pressing topics in oncology, from cutting-edge treatments and emerging research to personal stories of resilience and hope. More than just a podcast, it’s a platform for raising awareness, advancing cancer education, and fostering a global community of support and collaboration.
Hosted by NFCR CEO, Sujuan Ba, Ph.D., this compelling series will bring together the entire ecosystem of cancer research—including leading scientists, oncologists, doctors, patient advocates, caregivers, biotech innovators, and survivors—for powerful discussions on the breakthroughs shaping the future of cancer research, treatment, and care.
All Things Cancer is now available on Spotify and Apple Podcasts, with new episodes released biweekly.
Subscribe now to stay up to date on the latest episodes and join the conversation that’s shaping the future of cancer research. Cancer impacts everyone—whether you’re a patient, caregiver, advocate, or researcher, this podcast delivers invaluable insights from those on the frontlines of the fight against it.
